SLC1A5 and endometrial cancer: This is a strong indication of the important role of ASCT2-mediated glutamine metabolism in endometrial cancer cells, which is validated by our study and the findings that glutamine metabolism can be affected by P4 signaling, and that P4 inhibits glutamine uptake by suppressing ASCT2 expression.